Psychemedics Corporation (PMD)
USD 2.67
(0.0%)
USD 2.67
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.59 Million USD | -17.12% |
| 2022 | 7.96 Million USD | -14.48% |
| 2021 | 9.3 Million USD | -18.99% |
| 2020 | 11.49 Million USD | 7.28% |
| 2019 | 10.71 Million USD | 72.01% |
| 2018 | 6.22 Million USD | -21.06% |
| 2017 | 7.88 Million USD | -16.31% |
| 2016 | 9.42 Million USD | -11.83% |
| 2015 | 10.68 Million USD | -4.91% |
| 2014 | 11.24 Million USD | 163.09% |
| 2013 | 4.27 Million USD | 47.44% |
| 2012 | 2.89 Million USD | 4.76% |
| 2011 | 2.76 Million USD | 37.02% |
| 2010 | 2.01 Million USD | 54.34% |
| 2009 | 1.3 Million USD | -36.75% |
| 2008 | 2.06 Million USD | 22.88% |
| 2007 | 1.68 Million USD | -4.24% |
| 2006 | 1.75 Million USD | -21.91% |
| 2005 | 2.25 Million USD | 2.31% |
| 2004 | 2.19 Million USD | 2.02% |
| 2003 | 2.15 Million USD | 23.99% |
| 2002 | 1.73 Million USD | -25.57% |
| 2001 | 2.33 Million USD | 0.2% |
| 2000 | 2.33 Million USD | -2.84% |
| 1999 | 2.4 Million USD | -14.29% |
| 1998 | 2.8 Million USD | 27.27% |
| 1997 | 2.2 Million USD | 57.14% |
| 1996 | 1.4 Million USD | 100.0% |
| 1995 | 700 Thousand USD | 0.0% |
| 1994 | 700 Thousand USD | -22.22% |
| 1993 | 900 Thousand USD | 125.0% |
| 1992 | 400 Thousand USD | -33.33% |
| 1991 | 600 Thousand USD | -33.33% |
| 1990 | 900 Thousand USD | 125.0% |
| 1989 | 400 Thousand USD | 100.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 4.37 Million USD | -10.24% |
| 2024 Q1 | 4.87 Million USD | -26.17% |
| 2023 Q1 | 7.74 Million USD | -2.76% |
| 2023 FY | 6.59 Million USD | -17.12% |
| 2023 Q4 | 6.59 Million USD | -1.15% |
| 2023 Q3 | 6.67 Million USD | -8.05% |
| 2023 Q2 | 7.25 Million USD | -6.23% |
| 2022 Q4 | 7.96 Million USD | -9.08% |
| 2022 Q2 | 8.51 Million USD | 0.08% |
| 2022 Q1 | 8.5 Million USD | -8.62% |
| 2022 FY | 7.96 Million USD | -14.48% |
| 2022 Q3 | 8.75 Million USD | 2.84% |
| 2021 Q4 | 9.3 Million USD | -3.09% |
| 2021 Q2 | 11.47 Million USD | -0.83% |
| 2021 FY | 9.3 Million USD | -18.99% |
| 2021 Q1 | 11.56 Million USD | 0.67% |
| 2021 Q3 | 9.6 Million USD | -16.27% |
| 2020 Q1 | 9.4 Million USD | -12.22% |
| 2020 Q4 | 11.49 Million USD | 4.1% |
| 2020 FY | 11.49 Million USD | 7.28% |
| 2020 Q2 | 11.85 Million USD | 26.06% |
| 2020 Q3 | 11.03 Million USD | -6.87% |
| 2019 Q3 | 8.76 Million USD | 31.63% |
| 2019 Q1 | 7.03 Million USD | 12.99% |
| 2019 FY | 10.71 Million USD | 72.01% |
| 2019 Q4 | 10.71 Million USD | 22.22% |
| 2019 Q2 | 6.65 Million USD | -5.37% |
| 2018 Q2 | 8.16 Million USD | -4.56% |
| 2018 Q1 | 8.55 Million USD | 8.49% |
| 2018 FY | 6.22 Million USD | -21.06% |
| 2018 Q3 | 8.47 Million USD | 3.72% |
| 2018 Q4 | 6.22 Million USD | -26.5% |
| 2017 Q1 | 9.24 Million USD | -1.92% |
| 2017 Q3 | 8.22 Million USD | 14.06% |
| 2017 Q4 | 7.88 Million USD | -4.04% |
| 2017 FY | 7.88 Million USD | -16.31% |
| 2017 Q2 | 7.2 Million USD | -22.04% |
| 2016 Q4 | 9.42 Million USD | -21.63% |
| 2016 Q1 | 11.35 Million USD | 6.22% |
| 2016 Q3 | 12.02 Million USD | 2.89% |
| 2016 FY | 9.42 Million USD | -11.83% |
| 2016 Q2 | 11.68 Million USD | 2.95% |
| 2015 FY | 10.68 Million USD | -4.91% |
| 2015 Q3 | 11.12 Million USD | 3.7% |
| 2015 Q4 | 10.68 Million USD | -3.95% |
| 2015 Q2 | 10.73 Million USD | 2.68% |
| 2015 Q1 | 10.45 Million USD | -7.02% |
| 2014 Q1 | 5.58 Million USD | 30.82% |
| 2014 Q4 | 11.24 Million USD | 6.38% |
| 2014 Q3 | 10.56 Million USD | 4.51% |
| 2014 Q2 | 10.11 Million USD | 80.91% |
| 2014 FY | 11.24 Million USD | 163.09% |
| 2013 Q1 | 2.34 Million USD | -19.16% |
| 2013 Q3 | 2.99 Million USD | 20.88% |
| 2013 Q4 | 4.27 Million USD | 42.89% |
| 2013 FY | 4.27 Million USD | 47.44% |
| 2013 Q2 | 2.47 Million USD | 5.58% |
| 2012 FY | 2.89 Million USD | 4.76% |
| 2012 Q1 | 1.82 Million USD | -34.04% |
| 2012 Q4 | 2.89 Million USD | 6.01% |
| 2012 Q2 | 2.71 Million USD | 48.62% |
| 2012 Q3 | 2.73 Million USD | 0.82% |
| 2011 Q2 | 1.92 Million USD | 10.65% |
| 2011 Q1 | 1.73 Million USD | -13.82% |
| 2011 FY | 2.76 Million USD | 37.02% |
| 2011 Q3 | 1.73 Million USD | -9.88% |
| 2011 Q4 | 2.76 Million USD | 59.44% |
| 2010 FY | 2.01 Million USD | 54.34% |
| 2010 Q3 | 1.53 Million USD | 4.76% |
| 2010 Q4 | 2.01 Million USD | 31.55% |
| 2010 Q2 | 1.46 Million USD | 15.53% |
| 2010 Q1 | 1.26 Million USD | -3.06% |
| 2009 Q2 | 1.23 Million USD | -10.84% |
| 2009 Q4 | 1.3 Million USD | 7.74% |
| 2009 Q1 | 1.38 Million USD | -33.1% |
| 2009 FY | 1.3 Million USD | -36.75% |
| 2009 Q3 | 1.21 Million USD | -1.56% |
| 2008 FY | 2.06 Million USD | 22.88% |
| 2008 Q4 | 2.06 Million USD | 17.03% |
| 2008 Q2 | 1.74 Million USD | 11.46% |
| 2008 Q1 | 1.56 Million USD | -7.18% |
| 2008 Q3 | 1.76 Million USD | 1.49% |
| 2007 Q3 | 1.66 Million USD | 5.53% |
| 2007 Q2 | 1.57 Million USD | 20.38% |
| 2007 Q1 | 1.31 Million USD | -25.45% |
| 2007 FY | 1.68 Million USD | -4.24% |
| 2007 Q4 | 1.68 Million USD | 1.1% |
| 2006 Q2 | 1.92 Million USD | 20.12% |
| 2006 FY | 1.75 Million USD | -21.91% |
| 2006 Q4 | 1.75 Million USD | -13.07% |
| 2006 Q3 | 2.02 Million USD | 4.89% |
| 2006 Q1 | 1.6 Million USD | -28.7% |
| 2005 FY | 2.25 Million USD | 2.31% |
| 2005 Q2 | 2.08 Million USD | -20.47% |
| 2005 Q1 | 2.61 Million USD | 18.91% |
| 2005 Q4 | 2.25 Million USD | 1.4% |
| 2005 Q3 | 2.21 Million USD | 6.69% |
| 2004 Q3 | 2.61 Million USD | 25.04% |
| 2004 Q2 | 2.09 Million USD | -9.63% |
| 2004 Q1 | 2.31 Million USD | 7.3% |
| 2004 FY | 2.19 Million USD | 2.02% |
| 2004 Q4 | 2.19 Million USD | -15.86% |
| 2003 FY | 2.15 Million USD | 23.99% |
| 2003 Q2 | 2.18 Million USD | 12.1% |
| 2003 Q3 | 2.06 Million USD | -5.68% |
| 2003 Q4 | 2.15 Million USD | 4.46% |
| 2003 Q1 | 1.95 Million USD | 12.26% |
| 2002 FY | 1.73 Million USD | -25.57% |
| 2002 Q1 | 2.17 Million USD | -6.99% |
| 2002 Q2 | 2.69 Million USD | 24.15% |
| 2002 Q3 | 2.32 Million USD | -13.88% |
| 2002 Q4 | 1.73 Million USD | -25.16% |
| 2001 Q1 | 2.13 Million USD | -8.28% |
| 2001 Q2 | 2.76 Million USD | 29.09% |
| 2001 Q3 | 2.46 Million USD | -10.58% |
| 2001 FY | 2.33 Million USD | 0.2% |
| 2001 Q4 | 2.33 Million USD | -5.36% |
| 2000 FY | 2.33 Million USD | -2.84% |
| 2000 Q4 | 2.33 Million USD | -8.84% |
| 2000 Q3 | 2.55 Million USD | -14.36% |
| 2000 Q1 | 2.4 Million USD | 0.18% |
| 2000 Q2 | 2.98 Million USD | 24.23% |
| 1999 FY | 2.4 Million USD | -14.29% |
| 1999 Q1 | 2.6 Million USD | -7.14% |
| 1999 Q2 | 3.2 Million USD | 23.08% |
| 1999 Q4 | 2.4 Million USD | 9.09% |
| 1999 Q3 | 2.2 Million USD | -31.25% |
| 1998 Q1 | 3.2 Million USD | 45.45% |
| 1998 FY | 2.8 Million USD | 27.27% |
| 1998 Q4 | 2.8 Million USD | -9.68% |
| 1998 Q3 | 3.1 Million USD | 10.71% |
| 1998 Q2 | 2.8 Million USD | -12.5% |
| 1997 Q2 | 2.3 Million USD | 43.75% |
| 1997 Q3 | 2.6 Million USD | 13.04% |
| 1997 FY | 2.2 Million USD | 57.14% |
| 1997 Q1 | 1.6 Million USD | 14.29% |
| 1997 Q4 | 2.2 Million USD | -15.38% |
| 1996 Q1 | 700 Thousand USD | 0.0% |
| 1996 Q2 | 600 Thousand USD | -14.29% |
| 1996 FY | 1.4 Million USD | 100.0% |
| 1996 Q4 | 1.4 Million USD | 100.0% |
| 1996 Q3 | 700 Thousand USD | 16.67% |
| 1995 Q2 | 800 Thousand USD | -11.11% |
| 1995 FY | 700 Thousand USD | 0.0% |
| 1995 Q3 | 700 Thousand USD | -12.5% |
| 1995 Q4 | 700 Thousand USD | 0.0% |
| 1995 Q1 | 900 Thousand USD | 28.57% |
| 1994 Q3 | 700 Thousand USD | -22.22% |
| 1994 Q1 | 700 Thousand USD | -22.22% |
| 1994 FY | 700 Thousand USD | -22.22% |
| 1994 Q2 | 900 Thousand USD | 28.57% |
| 1994 Q4 | 700 Thousand USD | 0.0% |
| 1993 Q1 | 1 Million USD | 150.0% |
| 1993 Q2 | 1 Million USD | 0.0% |
| 1993 Q3 | 800 Thousand USD | -20.0% |
| 1993 Q4 | 900 Thousand USD | 12.5% |
| 1993 FY | 900 Thousand USD | 125.0% |
| 1992 FY | 400 Thousand USD | -33.33% |
| 1992 Q1 | 500 Thousand USD | -16.67% |
| 1992 Q4 | 400 Thousand USD | 0.0% |
| 1991 Q4 | 600 Thousand USD | 0.0% |
| 1991 Q1 | 1.2 Million USD | 33.33% |
| 1991 FY | 600 Thousand USD | -33.33% |
| 1990 Q4 | 900 Thousand USD | 0.0% |
| 1990 FY | 900 Thousand USD | 125.0% |
| 1989 Q2 | 200 Thousand USD | 0.0% |
| 1989 FY | 400 Thousand USD | 100.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 40.22 Million USD | 83.598% |
| Applied DNA Sciences, Inc. | 8.77 Million USD | 24.845% |
| Aspira Women's Health Inc. | 8.62 Million USD | 23.519% |
| Biodesix, Inc. | 94.51 Million USD | 93.019% |
| BioNexus Gene Lab Corp. | 1.74 Million USD | -278.773% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -96.002% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -96.002% |
| Bionano Genomics, Inc. | 118.24 Million USD | 94.42% |
| CareDx, Inc | 223.28 Million USD | 97.045% |
| Check-Cap Ltd. | 1.33 Million USD | -396.09% |
| Castle Biosciences, Inc. | 86.54 Million USD | 92.376% |
| DarioHealth Corp. | 38.24 Million USD | 82.748% |
| Exact Sciences Corporation | 3.32 Billion USD | 99.802% |
| Fulgent Genetics, Inc. | 139.82 Million USD | 95.281% |
| Guardant Health, Inc. | 1.62 Billion USD | 99.595% |
| ICON Public Limited Company | 7.74 Billion USD | 99.915% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | 99.628% |
| Illumina, Inc. | 4.36 Billion USD | 99.849% |
| Intelligent Bio Solutions Inc. | 5.59 Million USD | -17.913% |
| iSpecimen Inc. | 6.07 Million USD | -8.554% |
| Standard BioTools Inc. | 159.86 Million USD | 95.873% |
| MDxHealth SA | 121.92 Million USD | 94.588% |
| 23andMe Holding Co. | 206.64 Million USD | 96.807% |
| Medpace Holdings, Inc. | 1.09 Billion USD | 99.399% |
| Myriad Genetics, Inc. | 312.9 Million USD | 97.891% |
| Mainz Biomed B.V. | 12.15 Million USD | 45.739% |
| ENDRA Life Sciences Inc. | 1.09 Million USD | -502.471% |
| NeoGenomics, Inc. | 739.69 Million USD | 99.108% |
| Neogen Corporation | 1.44 Billion USD | 99.542% |
| Inotiv, Inc. | 588.04 Million USD | 98.878% |
| Natera, Inc. | 691.79 Million USD | 99.046% |
| OpGen, Inc. | 13.44 Million USD | 50.922% |
| OPKO Health, Inc. | 622.47 Million USD | 98.94% |
| Prenetics Global Limited | 44.01 Million USD | 85.009% |
| Prenetics Global Limited | 44.01 Million USD | 85.009% |
| Precipio, Inc. | 3.67 Million USD | -79.684% |
| Personalis, Inc. | 95.65 Million USD | 93.103% |
| RadNet, Inc. | 2.07 Billion USD | 99.682% |
| Sera Prognostics, Inc. | 25.28 Million USD | 73.903% |
| Sotera Health Company | 2.68 Billion USD | 99.754% |
| Neuronetics, Inc. | 81.64 Million USD | 91.918% |
| Star Equity Holdings, Inc. | 21.67 Million USD | 69.559% |
| Star Equity Holdings, Inc. | 21.67 Million USD | 69.559% |
| Trinity Biotech plc | 83.38 Million USD | 92.087% |
| T2 Biosystems, Inc. | 62.83 Million USD | 89.499% |
| Twist Bioscience Corporation | 152.97 Million USD | 95.687% |
| Exagen Inc. | 34.25 Million USD | 80.736% |